Literature DB >> 21356382

Blood-brain barrier disruption and oxidative stress in guinea pig after systemic exposure to modified cell-free hemoglobin.

Omer I Butt1, Paul W Buehler, Felice D'Agnillo.   

Abstract

Systemic exposure to cell-free hemoglobin (Hb) or its breakdown products after hemolysis or with the use of Hb-based oxygen therapeutics may alter the function and integrity of the blood-brain barrier. Using a guinea pig exchange transfusion model, we investigated the effect of a polymerized cell-free Hb (HbG) on the expression of endothelial tight junction proteins (zonula occludens 1, claudin-5, and occludin), astrocyte activation, IgG extravasation, heme oxygenase (HO), iron deposition, oxidative end products (4-hydroxynonenal adducts and 8-hydroxydeoxyguanosine), and apoptosis (cleaved caspase 3). Reduced zonula occludens 1 expression was observed after HbG transfusion as evidenced by Western blot and confocal microscopy. Claudin-5 distribution was altered in small- to medium-sized vessels. However, total expression of claudin-5 and occludin remained unchanged except for a notable increase in occludin 72 hours after HbG transfusion. HbG-transfused animals also showed increased astrocytic glial fibrillary acidic protein expression and IgG extravasation after 72 hours. Increased HO activity and HO-1 expression with prominent enhancement of HO-1 immunoreactivity in CD163-expressing perivascular cells and infiltrating monocytes/macrophages were also observed. Consistent with oxidative stress, HbG increased iron deposition, 4-hydroxynonenal and 8-hydroxydeoxyguanosine immunoreactivity, and cleaved caspase-3 expression. Systemic exposure to an extracellular Hb triggers blood-brain barrier disruption and oxidative stress, which may have important implications for the use of Hb-based therapeutics and may provide indirect insight on the central nervous system vasculopathies associated with excessive hemolysis. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21356382      PMCID: PMC3069891          DOI: 10.1016/j.ajpath.2010.12.006

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  62 in total

Review 1.  Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy.

Authors:  Hanne Van Gorp; Peter L Delputte; Hans J Nauwynck
Journal:  Mol Immunol       Date:  2010-03-17       Impact factor: 4.407

Review 2.  Toxicological consequences of extracellular hemoglobin: biochemical and physiological perspectives.

Authors:  Paul W Buehler; Felice D'Agnillo
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

Review 3.  CNS pericytes: concepts, misconceptions, and a way out.

Authors:  Martin Krueger; Ingo Bechmann
Journal:  Glia       Date:  2010-01-01       Impact factor: 7.452

4.  Hemoglobin-based oxygen carriers: current status and future directions.

Authors:  Toby A Silverman; Richard B Weiskopf
Journal:  Transfusion       Date:  2009-11       Impact factor: 3.157

5.  Heme oxygenase-1 induction protects murine cortical astrocytes from hemoglobin toxicity.

Authors:  R F Regan; Y Guo; N Kumar
Journal:  Neurosci Lett       Date:  2000-03-17       Impact factor: 3.046

6.  Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia.

Authors:  Elliott P Vichinsky; Lynne D Neumayr; Jeffrey I Gold; Michael W Weiner; Randall R Rule; Diana Truran; Jeffrey Kasten; Barry Eggleston; Karen Kesler; Lillian McMahon; Eugene P Orringer; Thomas Harrington; Karen Kalinyak; Laura M De Castro; Abdullah Kutlar; Cynthia J Rutherford; Cage Johnson; Joel David Bessman; Lanetta B Jordan; F Daniel Armstrong
Journal:  JAMA       Date:  2010-05-12       Impact factor: 56.272

Review 7.  Hemin toxicity: a preventable source of brain damage following hemorrhagic stroke.

Authors:  Stephen R Robinson; Theresa N Dang; Ralf Dringen; Glenda M Bishop
Journal:  Redox Rep       Date:  2009       Impact factor: 4.412

8.  In vitro and in vivo study on the antioxidant activity of dexrazoxane.

Authors:  Fabio Galetta; Ferdinando Franzoni; Giulia Cervetti; Francesco Regoli; Poupak Fallahi; Leonardo Tocchini; Angelo Carpi; Alessandro Antonelli; Mario Petrini; Gino Santoro
Journal:  Biomed Pharmacother       Date:  2009-10-24       Impact factor: 6.529

Review 9.  Heme degradation and vascular injury.

Authors:  John D Belcher; Joan D Beckman; Gyorgy Balla; Jozsef Balla; Gregory Vercellotti
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

10.  Differential induction of renal heme oxygenase and ferritin in ascorbate and nonascorbate producing species transfused with modified cell-free hemoglobin.

Authors:  Omer I Butt; Paul W Buehler; Felice D'Agnillo
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

View more
  32 in total

1.  Comparison of histological techniques to visualize iron in paraffin-embedded brain tissue of patients with Alzheimer's disease.

Authors:  Sara van Duijn; Rob J A Nabuurs; Sjoerd G van Duinen; Remco Natté
Journal:  J Histochem Cytochem       Date:  2013-07-25       Impact factor: 2.479

2.  Inhaled nitric oxide attenuates the adverse effects of transfusing stored syngeneic erythrocytes in mice with endothelial dysfunction after hemorrhagic shock.

Authors:  Chong Lei; Binglan Yu; Mohd Shahid; Arkadi Beloiartsev; Kenneth D Bloch; Warren M Zapol
Journal:  Anesthesiology       Date:  2012-12       Impact factor: 7.892

Review 3.  Blood substitutes: why haven't we been more successful?

Authors:  Abdu I Alayash
Journal:  Trends Biotechnol       Date:  2014-03-12       Impact factor: 19.536

4.  Nanoagonist-mediated endothelial tight junction opening: A strategy for safely increasing brain drug delivery in mice.

Authors:  Xihui Gao; Yuan-Cheng Wang; Yikang Liu; Qi Yue; Zining Liu; Mengjing Ke; Shengyuan Zhao; Cong Li
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 5.  Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.

Authors:  Meric A Altinoz; Emin M Ozcan; Bahri Ince; Sinan Guloksuz
Journal:  Metab Brain Dis       Date:  2016-05-28       Impact factor: 3.584

6.  Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.

Authors:  Todd L Mollan; Yiping Jia; Sambuddha Banerjee; Gang Wu; R Timothy Kreulen; Ah-Lim Tsai; John S Olson; Alvin L Crumbliss; Abdu I Alayash
Journal:  Free Radic Biol Med       Date:  2014-01-30       Impact factor: 7.376

7.  White Matter Brain Development after Exposure to Circulating Cell-Free Hemoglobin and Hyperoxia in a Rat Pup Model.

Authors:  Åsa Jungner; Suvi Vallius Kvist; Olga Romantsik; Matteo Bruschettini; Claes Ekström; Ivo Bendix; Josephine Herz; Ursula Felderhoff-Mueser; Adnan Bibic; René In Apos T Zandt; Magnus Gram; David Ley
Journal:  Dev Neurosci       Date:  2020-01-28       Impact factor: 2.984

8.  Down selection of polymerized bovine hemoglobins for use as oxygen releasing therapeutics in a guinea pig model.

Authors:  Jin Hyen Baek; Yipin Zhou; David R Harris; Dominik J Schaer; Andre F Palmer; Paul W Buehler
Journal:  Toxicol Sci       Date:  2012-03-12       Impact factor: 4.849

9.  Hemoglobin-induced nitric oxide synthase overexpression and nitric oxide production contribute to blood-brain barrier disruption in the rat.

Authors:  Shuo Yang; Yizhao Chen; Xinqing Deng; Weiping Jiang; Bing Li; Zhenghao Fu; Mouxuan Du; Rui Ding
Journal:  J Mol Neurosci       Date:  2013-03-15       Impact factor: 3.444

10.  Post-translational transformation of methionine to aspartate is catalyzed by heme iron and driven by peroxide: a novel subunit-specific mechanism in hemoglobin.

Authors:  Michael Brad Strader; Wayne A Hicks; Tigist Kassa; Eileen Singleton; Jayashree Soman; John S Olson; Mitchell J Weiss; Todd L Mollan; Michael T Wilson; Abdu I Alayash
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.